Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.044 | 0.7 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |